MedPath

Observational prospective study to evaluate clinical significance of statin therapy for secondary prevention in hemodialysis patients

Not Applicable
Conditions
Coronary artery disease
Registration Number
JPRN-UMIN000044529
Lead Sponsor
niversity of Yamanashi, Department of Internal Medicine II
Brief Summary

MACE occurred in 55 patients. Patients with MACE had significantly lower statin therapy. Multivariable Cox proportional hazards analysis showed that the patients on statins had significantly reduced rate of MACE occurrence.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
323
Inclusion Criteria

Not provided

Exclusion Criteria

The study patients met any of the following exclusion criteria were excluded: 1. Unsuccessful percutaneous coronary intervention 2. Died within 30 days after percutaneous coronary intervention

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The following outcomes during 3 years after discharge. 1. All cause mortality 2. Non-fatal myocardial infarction
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath